References
- Baranes J, Hellegouarch A, Le Hegarat M, Viossat I, Auguet M, Chabrier PE, Clostre F, Braquet, P (1986): The effects of PAF-acether on the cardiovascular system and their inhibi-tion by a new highly specific PAF-acether receptor antago-nist BN52021. Pharmacol Res Commun 18: 717–737
- Braquet P, Hosford D (1991): Ethnopharmacology and the development of natural PAF antagonist as therapeutic agents. J Ethnopharmacol 32: 135–139.
- Braquet P, Tougui L, Shen TY, Vargaftig BB (1987): Perspec-tives in platelet activating factor research. Pharmacol Rev 39: 97–145.
- Doebber TW, Wu MS, Robbins JC, Choy BM, Chang MN, Shen TY (1985): Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist, kadsurenone. Biochem Biophys Res Commun 29: 799–808.
- Goh SH, Jantan 1(1991): A xanthone from Calophyllum ino-phyllum. Phytochemistry 30: 366–367.
- Goh SH, Jantan I, Waterman PG (1992a): Neoflavonoid and biflavonoid constituents of Calophyllum inophylloide. J Nat Prod 55: 1415–1420.
- Goh SH, Jantan I, Gray Al, Waterman PG (1992b): Prenylated xanthones from Garcinia opaca Phytochemistry 31: 1383–1386.
- Hsueh W, Gonzalez Crussi F, Arroyave JL (1986): Platelet acti-vating factor-induced ischemic bowel necrosis. An investi-gation of secondary mediators in its pathogenesis. Am J Pathol 122: 231–239.
- Hwang SB, Lam MH (1991): L-659,989: A useful probe in the detection of multiple conformational states of PAF-receptors. Lipids 12: 1148–1153.
- Ito 0, Camussi G, Tetta C, Milgrom F, Andress G (1984): Hyper-acute renal allograft rejection in rabbit. The role of platelet-activating factor and cationic proteins derived from
- polymorphonuclear leukocytes and from platelets. Lab Invest 51: 148–161.
- Jantan I, Goh SH (1995): Flavonoids, xanthones and triterpenes of the leaves and heartwood of Garcinia bancana Mig. Sains Malaysiana 24: 23–30.
- Kloprogge E, Akkerman JW (1984): Binding kinetic of PAF-acether (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J 223: 901–909.
- Mallet AT, Curmingham FM (1985): Structural identification of platelet activating factor in psoriatic scale. Biochem Biophys Res Commun 126: 192–198.
- Valone FH, Coles E, Reinhold, VR, Goetzl EJ (1982): Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol 129: 1637–1641.
- Vargaftig BB, Braquet PG (1987): PAF-acether today: Rele-vance for acute experimental anaphylaxis. Br Med Bull 43: 312–335
- Yang HO, Suh DY, Han BH (1995): Isolation and characteriza-tion of platelet-activating factor receptor binding antago-nists from Biota orientalis. Planta Med 61: 37–40.